Back to Trades
Sell4
IONIS PHARMACEUTICALS INC
IONS
Total Value
$5.2M
Net $5.2M sold
Sales
$5.2M
1 transaction
Company Information
- Company Name
- IONIS PHARMACEUTICALS INC
- Ticker Symbol
- IONS
- CIK
- 0000874015
Insider Information
- Name
- Monia Brett P
- Role
- Chief Executive Officer, Director
- Location
- CARLSBAD, CA
DirectorOfficer
Filing Details
- Filing Date
- Feb 2, 2026
- Transaction Date
- Jan 29, 2026
- Accession Number
- 0000874015-26-000099
- Form Type
- 4
- Net Trading Amount
- -$5.2M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 29, 2026 | Common Stock | 122,214 | — | Grant/Award | — |
| Jan 30, 2026 | Common Stock | 62,970 | $82.72 | Sale | $5.2M |
Footnotes
- (F1)Represents shares earned upon the vesting of performance-based restricted stock units ("PRSUs") for the performance period of the grant to the reporting person reported on January 18, 2023. The Compensation Committee certified achievement of the pre-established performance goal based on the Issuer's relative total shareholder return as compared to a peer group of companies at a level resulting in a vest of 167.27% of target shares. As reported at grant, the PRSUs could result in a payout of 0% to 200% based on actual achievement of the goal.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.26 to $82.925 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.